Immediate Impact

1 by Nobel laureates 3 from Science/Nature 56 standout
Sub-graph 1 of 23

Citing Papers

Obstacles and opportunities in a forward vision for cancer nanomedicine
2021 Standout
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
2021 Standout
2 intermediate papers

Works of Debora Capelli being referenced

Thalidomide, Dexamethasone and Pegylated-Liposomal Doxorubicin (ThaDD) for Untreated Multiple Myeloma Patients Aged over 65 Years.
2005
Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience
2001

Author Peers

Author Last Decade Papers Cites
Debora Capelli 382 195 131 169 27 528
Pierre Hirsch 284 138 151 143 39 546
A Ferrant 336 169 186 109 27 611
R Cerri 358 143 115 119 30 486
M Masi 454 129 103 217 26 591
Cooper Mr 230 168 79 117 28 501
H M Golomb 268 140 132 110 23 519
M Boasson 294 181 96 138 35 532
Harald Biersack 194 233 69 214 33 546
Saburo Tsunoda 233 177 161 169 27 565
Anna Grazia Recchia 294 164 146 261 38 636

All Works

Loading papers...

Rankless by CCL
2026